Fig. 1From: Association between sodium glucose co-transporter 2 inhibitors and a reduced risk of heart failure in patients with type 2 diabetes mellitus: a real-world nationwide population-based cohort studyFlow chart of the sample selection, stratified by underlying cardiovascular disease. CVD cardiovascular disease, DM diabetes mellitus, DPP-4i dipeptidyl-peptidase IV inhibitor, N number, SGLT-2i sodium-glucose co-transporter 2 inhibitorBack to article page